{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:37:33Z","timestamp":1791632253873,"version":"4.3.4"},"reference-count":266,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["R01 DA037897"],"award-info":[{"award-number":["R01 DA037897"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["R21 DA045792"],"award-info":[{"award-number":["R21 DA045792"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["T32 DA028874"],"award-info":[{"award-number":["T32 DA028874"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["F31 DA058451"],"award-info":[{"award-number":["F31 DA058451"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.physbeh.2024.114565","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:58:39Z","timestamp":1713873519000},"page":"114565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence"],"prefix":"10.1016","volume":"281","author":[{"given":"Rae J.","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0646-5605","authenticated-orcid":false,"given":"Heath D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2024.114565_bib0001","series-title":"Smoking Cessation: A Report of the Surgeon General","year":"2020"},{"key":"10.1016\/j.physbeh.2024.114565_bib0002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults - United States","volume":"72","author":"Cornelius","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0003","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.15585\/mmwr.mm7140a3","article-title":"Notes from the field: e-cigarette use among middle and high school students - United States","volume":"71","author":"Cooper","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0004","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.15585\/mmwr.mm6749a1","article-title":"Frequency of use among middle and high school student tobacco product users - United States, 2015-2017","volume":"67","author":"Anic","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamapediatrics.2017.4200","article-title":"Errors in data input in meta-analysis on association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults","volume":"172","author":"Soneji","year":"2018","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.physbeh.2024.114565_bib0006","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamapediatrics.2017.1488","article-title":"Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis","volume":"171","author":"Soneji","year":"2017","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.physbeh.2024.114565_bib0007","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2105\/AJPH.92.6.990","article-title":"Benefits of smoking cessation for longevity","volume":"92","author":"Taylor","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.physbeh.2024.114565_bib0008","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","article-title":"Quitting smoking among adults - United States, 2000-2015","volume":"65","author":"Babb","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7105a1","article-title":"Tobacco product use and associated factors among middle and high school students \u2014 National Youth Tobacco Survey, United States, 2021","volume":"77","author":"Gentzke","year":"2022","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.physbeh.2024.114565_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245088","article-title":"The scientific case that nicotine is addictive","volume":"117","author":"Stolerman","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0011","first-page":"148","article-title":"Prevalence and factors associated with youth vaping cessation intention and quit attempts","author":"Dai","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.physbeh.2024.114565_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107886","article-title":"I cannot live without my vape\u201d: electronic cigarette user-identified indicators of vaping dependence","volume":"209","author":"Soule","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.physbeh.2024.114565_bib0013","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1037\/0278-6133.7.6.575","article-title":"Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace","volume":"7","author":"Klesges","year":"1988","journal-title":"Health Psychol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0014","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1037\/0022-006X.65.3.448","article-title":"Are weight concerns predictive of smoking cessation? A prospective analysis","volume":"65","author":"Meyers","year":"1997","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.2011.105","article-title":"Cigarette smoking, nicotine, and body weight","volume":"90","author":"Audrain-McGovern","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.physbeh.2024.114565_bib0016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40429-019-00253-3","article-title":"Tobacco smoking, eating behaviors, and body weight: a review","volume":"6","author":"Chao","year":"2019","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0017","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ajcn\/43.4.486","article-title":"Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids","volume":"43","author":"Stamford","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.physbeh.2024.114565_bib0018","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM199103143241106","article-title":"Smoking cessation and severity of weight gain in a national cohort","volume":"324","author":"Williamson","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0019","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/oby.21582","article-title":"The effect of tobacco cessation on weight gain, obesity and diabetes risk","volume":"24","author":"Bush","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pbb.2003.08.008","article-title":"Altered reward value of carbohydrate snacks for female smokers withdrawn from nicotine","volume":"76","author":"Spring","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0021","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0899-3289(10)80002-1","article-title":"Effects of smoking cessation on consumption of alcohol and sweet, high-fat foods","volume":"2","author":"Perkins","year":"1990","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.physbeh.2024.114565_bib0022","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2796.2003.01293.x","article-title":"Changes in blood pressure and body weight following smoking cessation in women","volume":"255","author":"Janzon","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0023","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(05)66511-7","article-title":"Smoking cessation, lung function, and weight gain: a follow-up study","volume":"365","author":"Chinn","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2024.114565_bib0024","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-152-1-201001050-00005","article-title":"Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study","volume":"152","author":"Yeh","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0033-0620(03)00087-2","article-title":"Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment","volume":"46","author":"Benowitz","year":"2003","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.physbeh.2024.114565_bib0026","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","article-title":"Consequences of smoking for body weight, body fat distribution, and insulin resistance","volume":"87","author":"Chiolero","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.physbeh.2024.114565_bib0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/07853890.2012.705016","article-title":"Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis","volume":"44","author":"Mills","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0028","article-title":"Interventions for preventing weight gain after smoking cessation","volume":"1","author":"Farley","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006219.pub2","article-title":"Interventions for preventing weight gain after smoking cessation","author":"Parsons","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2024.114565_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-021-01000-w","article-title":"Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery","volume":"12","author":"Lewis","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0032","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0033","series-title":"Gut-brain Axis and Addictive Disorders: A Review With Focus On Alcohol and Drugs of Abuse","first-page":"1","author":"Jerlhag","year":"2019"},{"key":"10.1016\/j.physbeh.2024.114565_bib0034","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.neubiorev.2021.10.026","article-title":"A novel approach to treating opioid use disorders: dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y(2) receptors","volume":"131","author":"Merkel","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0035","series-title":"GLP-influences Food and Drug Reward. Current Opinion in Behavioral Sciences","first-page":"66","author":"Hayes","year":"2016"},{"key":"10.1016\/j.physbeh.2024.114565_bib0036","first-page":"14","article-title":"The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies","author":"Jerlhag","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0037","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.physbeh.2019.03.026","article-title":"Central GLP-1 receptors: novel molecular targets for cocaine use disorder","volume":"206","author":"Hernandez","year":"2019","journal-title":"Physiol. Behav."},{"issue":"6","key":"10.1016\/j.physbeh.2024.114565_bib0038","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00213-023-06376-w","article-title":"Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats","volume":"240","author":"Herman","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0039","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn.4540","article-title":"GLP-1 acts on habenular avoidance circuits to control nicotine intake","volume":"20","author":"Tuesta","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2018.04.031","article-title":"Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity","volume":"1694","author":"Weina","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0041","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s43440-021-00274-8","article-title":"Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression","volume":"73","author":"Detka","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0042","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s10072-020-04910-8","article-title":"GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner","volume":"42","author":"Trammell","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0043","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","article-title":"Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem","volume":"77","author":"Larsen","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2024.114565_bib0044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/db18-0729","article-title":"Preproglucagon neurons in the nucleus of the solitary tract are the main source of brain GLP-1, mediate stress-induced hypophagia, and limit unusually large intakes of food","volume":"68","author":"Holt","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2024.114565_bib0045","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0046","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0047","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0048","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0049","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1042\/BST20150244","article-title":"The complexity of signalling mediated by the glucagon-like peptide-1 receptor","volume":"44","author":"Fletcher","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.physbeh.2024.114565_bib0050","series-title":"Glucagon-Like Peptide 1 (GLP-1)","first-page":"72","author":"M\u00fcller","year":"2019"},{"key":"10.1016\/j.physbeh.2024.114565_bib0051","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.cell.2016.05.023","article-title":"The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism","volume":"165","author":"Wootten","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.physbeh.2024.114565_bib0052","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1074\/jbc.M111.309369","article-title":"Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function","volume":"287","author":"Koole","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.physbeh.2024.114565_bib0053","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1124\/mol.110.065664","article-title":"Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening","volume":"78","author":"Koole","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0054","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bph.15497","article-title":"The therapeutic potential of GLP-1 receptor biased agonism","volume":"179","author":"Jones","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0055","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41467-018-03941-2","article-title":"Targeting GLP-1 receptor trafficking to improve agonist efficacy","volume":"9","author":"Jones","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.physbeh.2024.114565_bib0056","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1210\/jc.2002-021545","article-title":"Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes","volume":"88","author":"Kolterman","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0057","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.physbeh.2024.114565_bib0058","first-page":"S8","article-title":"The pharmacokinetic properties of glucagon-like peptide-1 receptor agonists and their mode and mechanism of action in patients with type 2 diabetes","volume":"67","author":"Anderson","year":"2018","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.physbeh.2024.114565_bib0059","doi-asserted-by":"crossref","first-page":"17208","DOI":"10.1038\/s41598-019-53356-2","article-title":"Pharmacokinetics of exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and bydureon","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0060","first-page":"10","article-title":"The discovery and development of liraglutide and semaglutide","author":"Knudsen","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0061","first-page":"92","volume":"7","author":"Crane","year":"2016"},{"key":"10.1016\/j.physbeh.2024.114565_bib0062","series-title":"Nutrition in the Prevention and Treatment of Abdominal Obesity (Second Edition)","first-page":"51","article-title":"Chapter 5 - pharmacologic agents chapter for abdominal obesity","author":"Nuffer","year":"2019"},{"key":"10.1016\/j.physbeh.2024.114565_bib0063","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0064","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-018-0800-2","article-title":"GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data","volume":"17","author":"Sposito","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0065","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.biopha.2018.08.088","article-title":"Recent updates on GLP-1 agonists: current advancements & challenges","volume":"108","author":"Sharma","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.physbeh.2024.114565_bib0066","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcph.443","article-title":"Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol\/levonorgestrel","volume":"55","author":"Kapitza","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0067","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s40262-017-0528-2","article-title":"Pharmacokinetics and tolerability of a single dose of semaglutide, a human glucagon-like peptide-1 analog, in subjects with and without renal impairment","volume":"56","author":"Marbury","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.physbeh.2024.114565_bib0068","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2337\/dc15-0165","article-title":"A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes","volume":"39","author":"Nauck","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2024.114565_bib0069","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dc17-0417","article-title":"Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial","volume":"41","author":"Ahmann","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2024.114565_bib0070","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/dc17-2381","article-title":"A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin","volume":"41","author":"Lingvay","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2024.114565_bib0071","series-title":"FDA Approves Novel, Dual-Targeted Treatment For Type 2 Diabetes","author":"Food","year":"2022"},{"key":"10.1016\/j.physbeh.2024.114565_bib0072","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0073","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13300-015-0127-x","article-title":"Comparison review of short-acting and long-acting glucagon-like peptide-1 receptor agonists","volume":"6","author":"Uccellatore","year":"2015","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.physbeh.2024.114565_bib0076","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3390\/ph3082554","article-title":"Exenatide use in the management of type 2 diabetes mellitus","volume":"3","author":"Kyriacou","year":"2010","journal-title":"Pharmaceuticals. (Basel)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0077","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/ijcp.12847","article-title":"Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials","volume":"70","author":"Xue","year":"2016","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.physbeh.2024.114565_bib0078","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821997320","article-title":"GLP-1 receptor agonists: an updated review of head-to-head clinical studies","volume":"12","author":"Trujillo","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0079","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0080","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI72434","article-title":"Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect","volume":"124","author":"Sisley","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2024.114565_bib0081","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0082","first-page":"5","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","author":"Gabery","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.physbeh.2024.114565_bib0083","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.22244","article-title":"Eating and hypothalamus changes in behavioral-variant frontotemporal dementia","volume":"69","author":"Piguet","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0084","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/en.2008-1045","article-title":"Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0085","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00250.2023","article-title":"Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss","volume":"326","author":"Buller","year":"2024","journal-title":"Am. J. Physiol.-Endocrinol. Metabol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0086","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2337\/db17-1385","article-title":"Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons","volume":"67","author":"Adams","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2024.114565_bib0087","first-page":"8","article-title":"The glucagon-like peptide 1 analogue exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice","author":"Egecioglu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2024.114565_bib0088","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/14622200802097506","article-title":"Sex differences in long-term smoking cessation rates due to nicotine patch","volume":"10","author":"Perkins","year":"2008","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0089","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00023210-200115050-00005","article-title":"Smoking cessation in women. Special considerations","volume":"15","author":"Perkins","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.physbeh.2024.114565_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04654-2","article-title":"Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum","volume":"9","author":"Wolfman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.physbeh.2024.114565_bib0091","series-title":"The Habenulo-Interpeduncular Pathway in Nicotine Aversion and Withdrawal","first-page":"213","author":"Antolin-Fontes","year":"2015"},{"key":"10.1016\/j.physbeh.2024.114565_bib0092","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.09.008","article-title":"Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability","volume":"76","author":"Fowler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0093","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuron.2011.04.013","article-title":"Aversion to nicotine is regulated by the balanced activity of \u03b24 and \u03b15 nicotinic receptor subunits in the medial habenula","volume":"70","author":"Frahm","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2024.114565_bib0094","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature09797","article-title":"Habenular \u03b15 nicotinic receptor subunit signalling controls nicotine intake","volume":"471","author":"Fowler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2024.114565_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112466","article-title":"GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity","author":"Falk","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0096","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41386-018-0010-3","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats","volume":"43","author":"Hernandez","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0097","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/adb.12583","article-title":"Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats","volume":"24","author":"Hernandez","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0098","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0099","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.physbeh.2017.03.019","article-title":"Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core","volume":"176","author":"Fortin","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0100","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/cne.23282","article-title":"Glucagon-like peptide-1 in the rat brain: distribution of expression and functional implication","volume":"521","author":"Gu","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0101","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2021.711750","article-title":"Glucagon-like peptide-1 agonist exendin-4 facilitates the extinction of cocaine-induced condition place preference","volume":"15","author":"Zhu","year":"2021","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0102","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbr.2010.10.037","article-title":"Extinction of drug seeking","volume":"217","author":"Millan","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0103","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am. J. Physiol. - Endocrinol. Metabol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0104","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuron.2017.09.042","article-title":"Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous glucagon-like peptide-1 in the paraventricular hypothalamus","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2024.114565_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2014.04.003","article-title":"Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex","volume":"190-191","author":"Ohtake","year":"2014","journal-title":"Regul. Pept."},{"key":"10.1016\/j.physbeh.2024.114565_bib0106","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fnins.2018.00756","article-title":"Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions","volume":"12","author":"Park","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/adb.12337","article-title":"Recent developments in the behavioural and pharmacological enhancement of extinction of drug seeking","volume":"22","author":"Chesworth","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nature01249","article-title":"Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour","volume":"421","author":"Sutton","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2024.114565_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","article-title":"Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure","author":"Epstein","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0110","first-page":"169","article-title":"Neurobiological and neurophysiological mechanisms underlying nicotine seeking and smoking relapse","volume":"4","author":"Schmidt","year":"2018","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0111","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.amjmed.2008.01.017","article-title":"Efficacy and safety of varenicline for smoking cessation","volume":"121","author":"Hays","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0112","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-009-1739-5","article-title":"The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats","volume":"208","author":"O'Connor","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0113","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1017\/S1461145711001398","article-title":"Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used","volume":"15","author":"Le Foll","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0114","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2024.114565_bib0115","first-page":"7","article-title":"Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial","author":"Klausen","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.physbeh.2024.114565_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2019.112771","article-title":"Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4","volume":"215","author":"Konanur","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FBP.0b013e328337be95","article-title":"Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats","volume":"21","author":"Liu","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0118","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1073\/pnas.1220591110","article-title":"Reinstatement of nicotine seeking is mediated by glutamatergic plasticity","volume":"110","author":"Gipson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2024.114565_bib0119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-0102(97)00074-6","article-title":"Nicotine induces long-lasting potentiation in the dentate gyrus of nicotine-primed rats","volume":"29","author":"Hamid","year":"1997","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0120","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1523\/JNEUROSCI.0458-10.2010","article-title":"Addictive nicotine alters local circuit inhibition during the induction of in vivo hippocampal synaptic potentiation","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0121","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/biof.1406","article-title":"Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus","volume":"44","author":"Rebosio","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.physbeh.2024.114565_bib0122","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1463-1326.2006.00589.x","article-title":"Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus","volume":"8","author":"Ratner","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0123","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials","volume":"19","author":"Bettge","year":"2017","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0124","doi-asserted-by":"crossref","first-page":"d7771","DOI":"10.1136\/bmj.d7771","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials","volume":"344","author":"Vilsb\u00f8ll","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.physbeh.2024.114565_bib0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0031-9384(76)90171-2","article-title":"Poison induced pica in rats","volume":"17","author":"Mitchell","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0126","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0127","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/0269881118756061","article-title":"Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats","volume":"32","author":"Babic","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0128","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ntr\/ntab066","article-title":"Exenatide adjunct to nicotine patch facilitates smoking cessation and may reduce post-cessation weight gain: a pilot randomized controlled trial","volume":"23","author":"Yammine","year":"2021","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101865","article-title":"Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial","volume":"57","author":"Lengsfeld","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.physbeh.2024.114565_bib0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-1844-1176","article-title":"The antiobesity effect and safety of GLP-1 receptor agonist in overweight\/obese patients without diabetes: a systematic review and meta-analysis","volume":"54","author":"Guo","year":"2022","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-13482-6_4","article-title":"Nicotine withdrawal","volume":"24","author":"McLaughlin","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0132","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-010-1848-1","article-title":"Meta-analysis of the acute effects of nicotine and smoking on human performance","volume":"210","author":"Heishman","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0133","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0278-6133.10.5.343","article-title":"A national survey of older smokers: treatment needs of a growing population","volume":"10","author":"Orleans","year":"1991","journal-title":"Health Psychol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0134","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.addbeh.2004.05.027","article-title":"Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome","volume":"30","author":"McKee","year":"2005","journal-title":"Addict. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/adb0000434","article-title":"Evaluating the temporal relationships between withdrawal symptoms and smoking relapse","volume":"33","author":"Robinson","year":"2019","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0136","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02244770","article-title":"The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat","volume":"115","author":"Malin","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0137","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3181\/0712-MR-355","article-title":"Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal","volume":"233","author":"De Biasi","year":"2008","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0138","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccm.2013.11.002","article-title":"Smoking cessation","volume":"35","author":"Rennard","year":"2014","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0139","first-page":"A14","article-title":"Behavioral risk factors associated with overweight and obesity among older adults: the 2005 National Health Interview Survey","volume":"6","author":"Kruger","year":"2009","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.physbeh.2024.114565_bib0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1360-0443.2010.03136.x","article-title":"Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers","volume":"106","author":"Lycett","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.physbeh.2024.114565_bib0141","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/oxfordjournals.aje.a009706","article-title":"Early and late weight gain following smoking cessation in the lung health study","volume":"148","author":"O'Hara","year":"1998","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0142","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2004.00131.x","article-title":"Smoking cessation and weight gain","volume":"5","author":"Filozof","year":"2004","journal-title":"Obes. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0143","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/0022-006X.65.2.286","article-title":"How much weight gain occurs following smoking cessation? A comparison of weight gain using both continuous and point prevalence abstinence","volume":"65","author":"Klesges","year":"1997","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0144","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0895-4356(93)90172-W","article-title":"Differential rates of relapse in subgroups of male and female smokers","volume":"46","author":"Swan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108819","article-title":"Tobacco withdrawal increases junk food intake: the role of the endogenous opioid system","volume":"225","author":"Anker","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.physbeh.2024.114565_bib0146","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2021.12.064","article-title":"A mouse model of weight gain after nicotine withdrawal","volume":"588","author":"Takeda","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2024.114565_bib0147","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pbb.2004.12.010","article-title":"Meal patterns in female rats during and after intermittent nicotine administration","volume":"80","author":"Bellinger","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00172879","article-title":"Effects of nicotine on body weight and food consumption in female rats","volume":"90","author":"Grunberg","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0149","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00427430","article-title":"Effects of nicotine on body weight and food consumption in rats","volume":"83","author":"Grunberg","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.14712\/18059694.2019.184","article-title":"Systemic nicotine administration suppresses food intake via reduced meal sizes in both male and female rats","volume":"41","author":"Bl\u00e1ha","year":"1998","journal-title":"Acta Medica (Hradec. Kralove)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0151","series-title":"Henry's Clinical Diagnosis and Management By Laboratory Methods E-book","author":"McPherson","year":"2021"},{"key":"10.1016\/j.physbeh.2024.114565_bib0152","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102429","article-title":"Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial","volume":"68","author":"L\u00fcthi","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.physbeh.2024.114565_bib0153","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes, Obes. Metabol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0154","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.physbeh.2024.114565_bib0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0039-6060(99)70163-7","article-title":"Nicotine's effect on hypothalamic neurotransmitters and appetite regulation","volume":"126","author":"Miyata","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.physbeh.2024.114565_bib0156","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0031-9384(01)00540-6","article-title":"Nicotine alters the usual reciprocity between meal size and meal number in female rat","volume":"74","author":"Miyata","year":"2001","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0157","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0091-3057(02)01033-X","article-title":"Meal patterns in male rats during and after intermittent nicotine administration","volume":"74","author":"Bellinger","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0158","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.physbeh.2004.02.015","article-title":"Food hedonics and reinforcement as determinants of laboratory food intake in smokers","volume":"81","author":"Epstein","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0159","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0091-3057(90)90192-K","article-title":"Chronic nicotine induces a specific appetite for sucrose in rats","volume":"35","author":"Jias","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0160","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1254\/jphs.FPE05001X","article-title":"Long-term effects of high doses of nicotine on feeding behavior and brain nitric oxide synthase activity in female mice","volume":"98","author":"Mannucci","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0161","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0091-3057(01)00676-1","article-title":"Cue dependency of nicotine self-administration and smoking","volume":"70","author":"Caggiula","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0162","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.physbeh.2011.04.043","article-title":"The reinforcement-enhancing effects of nicotine: implications for the relationship between smoking, eating and weight","volume":"104","author":"Donny","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0163","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1098\/rstb.2008.0107","article-title":"Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology","volume":"363","author":"Volkow","year":"2008","journal-title":"Philos. Trans. R. Soc. B: Biol. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0164","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/30001","article-title":"Dramatic decreases in brain reward function during nicotine withdrawal","volume":"393","author":"Epping-Jordan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2024.114565_bib0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopsych.2011.07.024","article-title":"Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens","volume":"71","author":"Zhang","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0166","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2011.01.024","article-title":"Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues","volume":"219","author":"Guy","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0167","doi-asserted-by":"crossref","first-page":"15475","DOI":"10.1073\/pnas.93.26.15475","article-title":"Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during\u2009nicotine\u2009withdrawal","volume":"93","author":"Heinrichs","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0168","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2010.12.007","article-title":"Effect of nicotine on feeding and body weight in rats: involvement of cocaine- and amphetamine-regulated transcript peptide","volume":"219","author":"Dandekar","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0169","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40265-017-0706-4","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the brain\u2013adipocyte axis","volume":"77","author":"Geloneze","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.physbeh.2024.114565_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.physbeh.2013.04.003","article-title":"Role of central glucagon-like peptide-1 in stress regulation","volume":"122","author":"Ghosal","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0171","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrendo.2016.32","article-title":"Metabolic effects of smoking cessation","volume":"12","author":"Harris","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0172","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biopsych.2004.10.022","article-title":"Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers","volume":"57","author":"Jacobsen","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0173","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuroimage.2010.04.251","article-title":"Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics","volume":"52","author":"Cole","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.physbeh.2024.114565_bib0174","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2009.07.020","article-title":"Working memory deficits predict short-term smoking resumption following brief abstinence","volume":"106","author":"Patterson","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.physbeh.2024.114565_bib0175","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.1168450","article-title":"Self-control in decision-making involves modulation of the vmPFC valuation system","volume":"324","author":"Hare","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2024.114565_bib0176","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nn.2321","article-title":"Motivation and cognitive control in the human prefrontal cortex","volume":"12","author":"Kouneiher","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0177","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17460441.2014.908180","article-title":"Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal","volume":"9","author":"Ashare","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.physbeh.2024.114565_bib0178","first-page":"76","article-title":"Cognitive function during nicotine withdrawal: implications for nicotine dependence treatment","author":"Ashare","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0179","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nrd2361","article-title":"Translational research in medication development for nicotine dependence","volume":"6","author":"Lerman","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.physbeh.2024.114565_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0181","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2011.04.010","article-title":"The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL\/6 mice","volume":"223","author":"Wilkinson","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0182","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/adb.12014","article-title":"Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats","volume":"19","author":"Kimmey","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0183","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1038\/npp.2012.83","article-title":"Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats","volume":"37","author":"Hopkins","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0184","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1038\/tp.2015.209","article-title":"Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers","volume":"6","author":"Ashare","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","article-title":"Varenicline improves mood and cognition during smoking abstinence","volume":"65","author":"Patterson","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0186","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1037\/a0025594","article-title":"Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers","volume":"20","author":"Ashare","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0187","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub5","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0188","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000031.pub3","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0189","doi-asserted-by":"crossref","first-page":"e14651","DOI":"10.14814\/phy2.14651","article-title":"Glucagon-like peptide-1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum-induced dementia","volume":"8","author":"Abd el-Rady","year":"2021","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2017.01.004","article-title":"Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects","volume":"321","author":"Palleria","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0191","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111529","article-title":"Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes","volume":"542","author":"Zhang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0192","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2010.10.008","article-title":"The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test","volume":"650","author":"Isacson","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0193","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainresbull.2018.02.002","article-title":"Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin","volume":"139","author":"Abdelwahed","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2024.114565_bib0194","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2021.107463","article-title":"GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK\/NF-\u03baB pathway in neuropathic pain mice","volume":"182","author":"Zhang","year":"2021","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.physbeh.2024.114565_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2022.12.089","article-title":"Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test","volume":"324","author":"Seo","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.physbeh.2024.114565_bib0196","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2016.02.003","article-title":"Neurobehavioral effects of liraglutide and sitagliptin in experimental models","volume":"774","author":"Kamble","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0197","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.3390\/ijms241411301","article-title":"Potential role of glucagon-like peptide-1 receptor agonists in the treatment of cognitive decline and dementia in diabetes mellitus","volume":"24","author":"Pelle","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0198","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41366-020-0535-5","article-title":"Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study","volume":"44","author":"Vadini","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.physbeh.2024.114565_bib0199","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020734","article-title":"Activation of glucagon-like peptide-1 receptor ameliorates cognitive decline in type 2 diabetes mellitus through a metabolism-independent pathway","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.physbeh.2024.114565_bib0200","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/dc21-2064","article-title":"Enhancement of impaired olfactory neural activation and cognitive capacity by liraglutide, but not dapagliflozin or acarbose, in patients with type 2 diabetes: a 16-week randomized parallel comparative study","volume":"45","author":"Cheng","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2024.114565_bib0201","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0202","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbi.2018.11.003","article-title":"Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice","volume":"75","author":"Saravia","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2024.114565_bib0203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","article-title":"Diabetes and cognitive impairment","volume":"16","author":"Zilliox","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.physbeh.2024.114565_bib0204","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050327","article-title":"Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies","volume":"132","author":"Crawley","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2024.114565_bib0206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0207","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-3057(01)00651-7","article-title":"Neurobiology of the nicotine withdrawal syndrome","volume":"70","author":"Kenny","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0208","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2024.114565_bib0209","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.neuropharm.2008.03.013","article-title":"Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL\/6J and BALB\/cByJ mice","volume":"54","author":"Stoker","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.physbeh.2024.114565_bib0211","first-page":"18","article-title":"The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior","author":"Schmidt","year":"2007","journal-title":"Behav. Pharmacol."},{"issue":"Suppl 6","key":"10.1016\/j.physbeh.2024.114565_bib0212","first-page":"007","article-title":"Passive response to stress in adolescent female and adult male mice after intermittent nicotine exposure in adolescence","author":"Thanos","year":"2013","journal-title":"J. Addict. Res. Ther."},{"key":"10.1016\/j.physbeh.2024.114565_bib0213","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114053","article-title":"The effect of glucagon like peptide-1 receptor agonist on behavioral despair and anxiety-like behavior in ovariectomized rats: modulation of BDNF\/CREB, Nrf2 and lipocalin 2","volume":"435","author":"Sa\u011flam","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0214","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121546","article-title":"Dulaglutide impedes depressive-like behavior persuaded by chronic social defeat stress model in male C57BL\/6 mice: implications on GLP-1R and cAMP\/PKA signaling pathway in the hippocampus","volume":"320","author":"Darwish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/JPD-171068","article-title":"Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines","volume":"7","author":"Ventorp","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.physbeh.2024.114565_bib0216","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/02699052.2019.1587000","article-title":"GLP-1\u2019s role in neuroprotection: a systematic review","volume":"33","author":"Erbil","year":"2019","journal-title":"Brain Inj."},{"key":"10.1016\/j.physbeh.2024.114565_bib0217","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM198808183190706","article-title":"Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)","volume":"319","author":"Gold","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0218","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression","volume":"35","author":"Zunszain","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0219","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/npp.2011.151","article-title":"Functional biomarkers of depression: diagnosis, treatment, and pathophysiology","volume":"36","author":"Schmidt","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0220","first-page":"151","article-title":"The effect of cigarette smoking on adrenal cortical hormones","volume":"272","author":"Baron","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2024.114565_bib0221","first-page":"1310","article-title":"The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men","volume":"79","author":"Field","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0222","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.psy.0000204926.27215.a1","article-title":"Reduction in cortisol after smoking cessation among users of nicotine patches","volume":"68","author":"Ussher","year":"2006","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0223","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0306-4530(03)00024-6","article-title":"Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation","volume":"29","author":"Semba","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0224","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0006-3223(97)00423-X","article-title":"Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers","volume":"43","author":"Frederick","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2382","article-title":"Cortisol levels decrease after acute tobacco abstinence in regular smokers","volume":"29","author":"Wong","year":"2014","journal-title":"Human Psychopharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0226","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10253890.2020.1823367","article-title":"Blunted opioid regulation of the HPA stress response during nicotine withdrawal: therapeutic implications","volume":"24","author":"Absi","year":"2021","journal-title":"Stress"},{"key":"10.1016\/j.physbeh.2024.114565_bib0227","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1210\/en.2009-0915","article-title":"GLP-1(7-36)-amide and exendin-4 stimulate the HPA axis in rodents and humans","volume":"151","author":"Gil-Lozano","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0228","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00529.2012","article-title":"Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance","volume":"304","author":"Gil-Lozano","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0229","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ejn.14631","article-title":"Gut microbiota-brain axis in depression: the role of neuroinflammation","volume":"53","author":"Carlessi","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165267","article-title":"Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-A multicenter pilot analysis","volume":"11","author":"Setoyama","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2024.114565_bib0231","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1570159X14666160229114755","article-title":"Mitochondrial dysfunction in depression","volume":"14","author":"Bansal","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0232","doi-asserted-by":"crossref","first-page":"e59260","DOI":"10.1371\/journal.pone.0059260","article-title":"Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans","volume":"8","author":"Biedermann","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2024.114565_bib0233","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10863-019-09800-z","article-title":"Mitochondria as a possible target for nicotine action","volume":"51","author":"Mali\u0144ska","year":"2019","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.physbeh.2024.114565_bib0234","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","article-title":"Liraglutide modulates gut microbiota and reduces NAFLD in obese mice","volume":"62","author":"Moreira","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.physbeh.2024.114565_bib0235","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/jcp.29204","article-title":"Role of liraglutide in brain repair promotion through Sirt1-mediated mitochondrial improvement in stroke","volume":"235","author":"He","year":"2020","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0236","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3803\/EnM.2015.30.2.216","article-title":"Glucagon-like peptide-1 increases mitochondrial biogenesis and function in INS-1 rat insulinoma cells","volume":"30","author":"Kang","year":"2015","journal-title":"Endocrinol. Metab. (Seoul)."},{"key":"10.1016\/j.physbeh.2024.114565_bib0237","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40265-015-0347-4","article-title":"Depression in type 2 diabetes mellitus: prevalence, impact, and treatment","volume":"75","author":"Semenkovich","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.physbeh.2024.114565_bib0238","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","article-title":"Depression and obesity: evidence of shared biological mechanisms","volume":"24","author":"Milaneschi","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2024.114565_bib0239","first-page":"13","article-title":"Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort study","author":"Tsai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105715","article-title":"Diabetes, antidiabetic medications and risk of depression \u2013 a population-based cohort and nested case-control study","volume":"140","author":"Wium-Andersen","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0241","first-page":"257","author":"Pozzi","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.physbeh.2024.114565_bib0242","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023830","article-title":"Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink","volume":"8","author":"Gamble","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.physbeh.2024.114565_bib0243","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.2337\/dc20-1561","article-title":"Antidiabetes agents and incident depression: a nationwide population-based study","volume":"43","author":"Kessing","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2024.114565_bib0244","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41591-023-02672-2","article-title":"Association of semaglutide with risk of suicidal ideation in a real-world cohort","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpsychires.2023.05.041","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review","volume":"164","author":"Cooper","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.physbeh.2024.114565_bib0246","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0002-8703(81)90197-6","article-title":"Update on the role of cigarette smoking in coronary artery disease","volume":"101","author":"Kannel","year":"1981","journal-title":"Am. Heart J."},{"key":"10.1016\/j.physbeh.2024.114565_bib0247","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1093\/eurheartj\/ehab578","article-title":"Smoking cessation, but not reduction, reduces cardiovascular disease incidence","volume":"42","author":"Jeong","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.physbeh.2024.114565_bib0248","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jclinepi.2005.02.019","article-title":"In a prospective study in young people, associations between changes in smoking behavior and risk factors for cardiovascular disease were complex","volume":"58","author":"Bernaards","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0249","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.physbeh.2024.114565_bib0250","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00380-014-0549-9","article-title":"The effects of weight gain after smoking cessation on atherogenic \u03b11-antitrypsin-low-density lipoprotein","volume":"30","author":"Komiyama","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.physbeh.2024.114565_bib0251","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1803626","article-title":"Smoking cessation, weight change, type 2 diabetes, and mortality","volume":"379","author":"Hu","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0252","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1056-8727(00)00065-9","article-title":"Cardiovascular risk in diabetes: a brief review","volume":"14","author":"Marks","year":"2000","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.physbeh.2024.114565_bib0253","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0254","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2024.114565_bib0255","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dom.14890","article-title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses","volume":"25","author":"Kosiborod","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0256","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-\/-) and LDLr(-\/-) mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0257","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/sj.npp.1300780","article-title":"Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues","volume":"30","author":"McClernon","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2024.114565_bib0258","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diabres.2019.01.033","article-title":"Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: an integrative review","volume":"149","author":"Yammine","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.physbeh.2024.114565_bib0259","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1462-8902.2004.00329.x","article-title":"Smoking cessation and glycaemic control in type 2 diabetic patients","volume":"6","author":"Iino","year":"2004","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.physbeh.2024.114565_bib0260","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S2213-8587(15)00082-0","article-title":"The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study","volume":"3","author":"Lycett","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0261","article-title":"Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials","volume":"4","author":"Alexander","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.physbeh.2024.114565_bib0262","series-title":"A Woman Who Smoked Up to a Pack of Cigarettes a Day Found Them 'Disgusting' When She Started Taking Ozempic. Now She Hasn't Smoked in 6 Months","author":"Medaris","year":"2023"},{"key":"10.1016\/j.physbeh.2024.114565_bib0263","series-title":"Can Diabetes and Weight-Loss Drug Ozempic Break Addictions Too?","author":"Lu","year":"2023"},{"key":"10.1016\/j.physbeh.2024.114565_bib0264","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrendo.2015.7","article-title":"The endocrinology of taste receptors","volume":"11","author":"Calvo","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2024.114565_bib0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1749-6632.2009.03920.x","article-title":"Modulation of taste sensitivity by GLP-1 signaling in taste buds","volume":"1170","author":"Martin","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.physbeh.2024.114565_bib0266","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1471-4159.2008.05397.x","article-title":"Modulation of taste sensitivity by GLP-1 signaling","volume":"106","author":"Shin","year":"2008","journal-title":"J. Neurochem."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938424001100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938424001100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:37:19Z","timestamp":1716532639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938424001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":266,"alternative-id":["S0031938424001100"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2024.114565","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2024.114565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114565"}}